Publications

Selected Publications

 

Cancer Mutations in FGFR2 Prevent a Negative Feedback Loop Mediated by the ERK1 / 2 Pathway. Szybowska P, Kostas M, Wesche J, Wiedlocha A, Haugsten EM,  Cells. May 29; 8 (6)  2019.  Pubmed

Crosstalk between p38 and Erk 1/2 in Downregulation of FGF1-Induced Signaling. Zakrzewska M, Opalinski L,  Haugsten EM , Otlewski J,  Wiedlocha A,  Int J Mol Sci, 20 (8)  2019.  Pubmed

Protein Tyrosine Phosphatase Receptor Type G (PTPRG) Controls Fibroblast Growth Factor Receptor (FGFR) 1 Activity and Influences Sensitivity to FGFR Kinase Inhibitors. Kostas MHaugsten EMZhen YSørensen VSzybowska PFiorito ELorenz S , Jones N, de Souza GA,  Wiedlocha AWesche J. Molecular & Cellular Proteomics, 2018 MayPubMed

Proximity Labeling by a Recombinant APEX2-FGF1 Fusion Protein Reveals Interaction of FGF1 with the Proteoglycans CD44 and CSPG4. Zhen YHaugsten EMSingh SKWesche J. Biochemistry, 2018 JulPubMed

The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases. Fafilek B, Balek L, Bosakova MK, Varecha M, Nita A, Gregor T, Gudernova I, Krenova J, Ghosh S, Piskacek M, Jonatova L, Cernohorsky NH, Zieba JT,  Kostas MHaugsten EMWesche J , Erneux C , Trantirek L, Krakow D, Krejci P.  Sci Signal. 2018 Sep. PubMed

Complete list of Publications

Published Apr. 8, 2022 10:20 AM - Last modified Apr. 8, 2022 10:23 AM